Latest & greatest articles for oxycodone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on oxycodone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on oxycodone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for oxycodone

21. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin (Abstract)

A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin The aim of this randomized double-blind, placebo-controlled, parallel-group study was to evaluate the efficacy, safety, and tolerability of pregabalin in combination with oxycodone or placebo, in patients with either postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN). After a 7-day washout period, 62 patients were randomized (...) to receive either oxycodone mixture 10 mg/day or placebo mixture for 1 week. Patients were then started on open-label pregabalin (75, 150, 300 and 600 mg/day) according to a forced titration dosing regimen, while continuing the same dosage of oxycodone or placebo for 4 weeks. The primary efficacy measure was a decrease in the pain-intensity score of at least 2cm and a pain score <4cm measured using a 10-cm visual analogue scale (VAS) following pregabalin dosage escalation and treatment for 4 weeks

2010 EvidenceUpdates Controlled trial quality: predicted high

22. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients (Abstract)

The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients Most treatments of acute pain associated with non-malignant chronic pains are not satisfactory. The aim of this study is to evaluate the efficacy and side effects of oxycondone controlled release (Oxy-CR) in managing chronic neck pain with acute pain episodes.Randomised, double-blind, stand controlled study. A total of 116 patients were evenly divided into an oxycodone group (Oxy-CR, 5-10 mg and q12 h

2008 EvidenceUpdates Controlled trial quality: uncertain

23. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone Full Text available with Trip Pro

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release (...) oxycodone and OROS hydromorphone Ward A, Bozkaya D, Fleischmann J, Dubois D, Sabatowski R, Caro J J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of the Osmotic controlled-Release Oral

2007 NHS Economic Evaluation Database.

24. Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Full Text available with Trip Pro

Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain Article Text Therapeutics Buccal oxycodone reduced pain more than placebo in children

2006 Evidence-Based Medicine

25. Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy

Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.